Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2026.110 | Safety and Lesion Durability of Pulsed Field Ablation to Lateral Mitral Isthmus |
Prof. Tam Tsz Kin 譚子健 |
| 2026.402 | Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects with Atrial Fibrillation – A Global Prospective Single Arm Study The FARADIGM Study |
Prof. Tam Tsz Kin 譚子健 |
| 2026.526 | Modulation of Ventricular Rate via Atrioventricular Nodal Nerve Stimulation in Atrial Fibrillation (MODULATE-AF) |
Prof. Tam Tsz Kin 譚子健 |
| 2023.467 | Peri-operative Hemodynamic Data in Predicting Procedural Outcomes using Machine Learning |
Dr. TAM Tsz Kin 譚子健 |
| 2023.144 | Atrioventricular node ablation with pulse field energy in patients for rate control in patients with persistent atrial fibrillation |
Dr. TAM Tsz Kin 譚子健 |
| 2025.566 | Cardioneural temporary pacing to achieve autonomic modulation |
Dr. TAM Tsz Kin 譚子健 |
| 2025.474 | Randomized trial of ELEVATEd cardiac pacing rate for personalized treatment of Heart Failure with preserved Ejection Fraction (ELEVATE-HFpEF) |
Prof. TAM Tsz Kin 譚子健 |
| 2025.163 | Pulsed field ablation for cavotricuspid isthmus dependent atrial flutter cohort study | Prof. TAM Tsz Kin |
| 2025.268 | Cardio-neural pacing to modulate AV conduction in persistent AF patients – a feasibility study |
Prof. TAM Tsz Kin 譚子健 |
| 2024.493 | Prince of Wales Hospital Cardiac Electrophysiology Procedural Registry | Prof. TAM Tsz Kin |
| 2024.658 | Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia (OPTION-A) |
Prof. TAM Tsz Kin 譚子健 |
| 2025.059 | Personalizing Heart failure Device therapy by ECG imaging – a multicenter randomized controlled trial |
Prof. TAM Tsz Kin 譚子健 |
| 2024.399 | Combined Leadless Pacemaker and Left Atrial Appendage Occlusion Registry |
Prof. TAM Tsz Kin 譚子健 |
| 2025.815 | Comparison of combination of different medications in patients with atherosclerotic cardiovascular disease and co-morbidities in Hong Kong |
Prof. Tam Tsz Kin 譚子健 |
| 2023.600 | Leadless Pacemaker Comparison Study |
Dr. TAM Tsz Kin 譚子健 |
| 2025.784 | A Global Randomized Trial Comparing Pulsed Field Ablation of Pulmonary Veins plus Extra-PV Sources utilizing Electrographic Flow Mapping Versus Pulmonary Veins plus Posterior Wall in Persistent Atrial Fibrillation Patients. (OPTIMIZE) |
Prof. TAM Tsz Kin 譚子健 |
| 2026.019 | Leadless atrial pacing in the management of HFpEF |
Prof. Tam Tsz Kin 譚子健 |
| 2025.816 | Treatment Landscape of Patients with Heart Failure in Hong Kong |
Prof. Tam Tsz Kin 譚子健 |
| 2018.405 | Intraoperative Use of Non-invasive Cardiac Output Monitoring versus Standard Fluid Management in Free Perforator Flap Surgery: A Randomized Pilot Trial |
Dr. TAM Suet Yee 談雪儀 |
| 2009.114 | Randomised Controlled Trial of Two Algorithms for Weaning Cardiac Surgical Patients Using Adaptive Support Ventilation Mode. A Comparison of Duration of Ventilation | Dr. Tam Paul Man Kei |
| 2011.210 | Genetic adaption to chronic hypoxia: Genome-wide search for genetic adaptions in highland inhabitants and patients with mountain sickness | Prof. TAM Michael Siu Cheung |
| 2018.371 | Tricuspid regurgitation after cardiac implantable electronic device implantation | Dr. TAM Mark Tsz Kin |
| 2024.179 | Leadless pacemaker implantation positions and its relationship with procedure efficacy and complication |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2023.685 | A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation (AVANT GUARD) |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2024.350 | Catheter Ablation in Atrial Fibrillation Patients with Heart Failure with Preserved Ejection Fraction: an International, Prospective, Multi-center, Randomized Controlled study |
Prof. TAM Mark Tsz Kin 譚子健 |
| 2024.184 | Smartwatch paroxysmal arrhythmia detection compared with Holter - a multicenter controlled trial |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2024.662 | A Stylet-Driven ICD Lead Intended for Conduction System Pacing IDE Study |
Prof. TAM Mark Tsz Kin 譚子健 |
| 2025.045 | Cardiovascular physiological signal recording project |
Prof. TAM Mark Tsz Kin 譚子健 |
| 2024.028 | Coronary study in patients undergoing AF ablation |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2022.456 | Atrial fibrillation ablation registry |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2022.505 | Artificial intelligence to improve procedure safety of atrioventricular nodal reentrant tachycardia ablation – a retrospective feasibility study | Dr. TAM Mark Tsz Kin |
| 2023.406 | Drug - drug interaction (DDI) of direct oral anticoagulants database research |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2023.332 | Leadless Pacemaker Registry |
Dr. TAM Mark Tsz Kin 譚子健 |
| 2025.368 | Retention rate of adalimumab bio-original and biosimilars in rheumatic diseases: a real-world study from the Hong Kong Biologics Registry |
Dr. TAM Lydia Ho Pui 譚皓珮 |
| 2025.218 | Clinical characteristics and outcomes of patients with Adult-Onset Still’s Disease (AOSD) in Hong Kong | Dr. TAM Lydia Ho Pui |
| 2021.663 | A retrospective study to evaluate the pulmonologist-pharmacist care model at the pharmacist respiratory clinic in an acute teaching hospital in Hong Kong. | Ms. TAM Lyanna Lik Yan |
| 2011.558 | RAGE: a new therapeutic target and biomarker of rheumatoid arthritis | Professor Tam Lai-Shan |
| 2012.082 | Periatricular and generalized bone loss in psoriatic arthritis | Prof. Tam Lai-Shan |
| 2011.276 | Ankylosing spondylitis vascular study | Prof. TAM Lai-Shan |
| 2011.209 | Assessment of PROMIS Fatigue Bank with SLE-specfic items for use in an Asian SLE population in Hong Kong and Singapore | Prof. TAM Lai-Shan |
| 2011.050 | A Randomized, Double-Blind Phase 2b Study to Evaluate the Efficacy, Safety, and Tolerability of A-623 Administration in Subjects with Systemic Lupus Erythematosus | Professor Tam Lai-Shan |
| 2011.562 | An Open-Label Long-term Safety Extension Trial for Subjects with Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 (PEARL-SC) | Professor Tam Lai-Shan |
| 2008.159 | A Phase IIb, Multi-center, Open-label, Follow-up Study to Assess the Safety and Efficacy of Epratuzumab in Serologically-Positive Systemic Lupus Erythematosus Patients with Active Disease Who Participated in Study SL0007 | Asso. Prof. TAM Lai Shan |
| 2008.160 | SERAPHIN: Study with Endothelin Receptor Antagonist in Pulmonary Arterial Hypertension to Improve Clinical Outcome | Prof Tam Lai Shan |
| 2008.161 | SERAPHIN-OL: Study with An ERA in Pulmonary Arterial Hypertension to Improve Clinical Outcome (Open Label) – Long-term Single-arm Open-label Extension Study of the SERAPHIN study, to Assess the Safety and Tolerability of ACT-064922 in Patients with Symptomatic Pulmonary Arterial Hypertension | Prof. TAM Lai Shan |
| 2012.476 | Alteration in bone density and microstructure in early rheumatoid arthritis and its relationship with bone erosion: A one-year study by HR-pQCT and MRI | Prof. TAM Lai Shan |
| 2010.298 | A randomized, double-blind, parallel group study of the safety and effect on clinical outcome of tocilizumab SC versus tocilizumab IV, in combination with traditional disease modifying anti-rheumatoid arthritis drugs (DMARDs), in patients with moderate to severe active rheumatoid arthritis | Prof. Tam Lai Shan |
| 2013.568 | A 48 weeks, phase II, randomized, double-blind, placebo-controlled, proof of concept and dose finding study of three different dose regimens of BI 655066 administered subcutaneously in patients with ankylosing spondylitis. | Prof. TAM Lai Shan |
| 2014.167 | Exploiting the immunomodulatory and anti-inflammatory role of IL35 to modulate inflammation and autoreactive B cell activation in rheumatoid arthritis | Prof. TAM Lai Shan |
| 2013.470 | A multi-center, uncontrolled extension study evaluating efficacy and safety of SAR153191 on top of DMARDs in patients with active Rheumatoid Arthritis (RA) | Prof Tam Lai Shan |
Page 70 of 289.